as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
-0.07%
Downside
4.19%
Upside
52 Week's Low
52 Week's High
45.40%
Downside
29.24%
Upside
Check Kalvista Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$707.8M
EPS (TTM)
-3.56
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-14.79
Industry PE ratio
0.4226599326599327
P/B Ratio
0PEG Ratio
0EBITDA
-201.8M
Revenue (TTM)
1.4M
Profit Margin
0.00%
Return On Equity TTM
7374400.00%
Track how Kalvista Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Kalvista Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 17, 2025
Today (-14.79x)
September 17, 2025
Industry (0.42x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: -14.79x
Compare market cap, revenue, PE, and other key metrics of Kalvista Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $707.8M | 4.63% | -14.79 | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Kalvista Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kalvista Pharmaceuticals Inc investment value today
Current value as on today
₹1,31,088
Returns
₹31,088
(+31.09%)
Returns from Kalvista Pharmaceuticals Inc Stock
₹26,490 (+26.49%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Kalvista Pharmaceuticals Inc. Average target price of $31.67
Get share price movements and forecasts by analysts on Kalvista Pharmaceuticals Inc.
What analysts predicted
57.78%UPSIDE
Target Price
$31.67
Current Price
$13.37
Analyzed by
12 Analysts
Target
$31.67
Kalvista Pharmaceuticals Inc target price $31.67, a slight upside of 57.78% compared to current price of $13.37. According to 12 analysts rating.
Search interest for Kalvista Pharmaceuticals Inc Stock has increased by 135% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:135% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 September
Fri, 06:16 PM
-Analyst Andrew Fein maintains Buy rating on KalVista, citing strong early launch metrics for Ekterly and a price target of $27.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 42.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 126.4%
Price Dip
In the last 7 days, KALV stock has moved down by -8.8%
Organisation | Kalvista Pharmaceuticals Inc |
Headquarters | 55 Cambridge Parkway, Cambridge, MA, United States, 02142 |
Industry | Health Technology |
CEO | Mr. Benjamin L. Palleiko |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Brian Krex J.D. | General Counsel |
Ms. Rachel M. Morten | Senior Vice President of Regulatory Affairs & QA |
Dr. Christopher M. Yea Ph.D. | Chief Development Officer |
Dr. Michael D. Smith Pharm.D. | Senior Vice President of Development |
Mr. Brian Piekos | Chief Financial Officer |
Dr. Paul K. Audhya M.B.A., M.D. | Chief Medical Officer |
Mr. Ryan Baker | Head of Investor Relations |
Mr. Benjamin L. Palleiko | CEO & Director |
Jarrod Aldom | Vice President of Corporate Communications |
Ms. Nicole Sweeny | Chief Commercial Officer |
Kalvista Pharmaceuticals Inc share price today is $13.37 as on at the close of the market. Kalvista Pharmaceuticals Inc share today touched a day high of $13.93 and a low of $13.38.
Kalvista Pharmaceuticals Inc share touched a 52 week high of $17.28 on and a 52 week low of $7.3 on . Kalvista Pharmaceuticals Inc stock price today i.e. is closed at $13.37,which is 22.63% down from its 52 week high and 83.15% up from its 52 week low.
Kalvista Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kalvista Pharmaceuticals Inc (KALV) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Kalvista Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kalvista Pharmaceuticals Inc share’s latest price of $13.37 as on September 18, 2025 at 1:29 am IST, you will get 0.7479 shares of Kalvista Pharmaceuticals Inc. Learn more about
fractional shares .
Kalvista Pharmaceuticals Inc stock has given 4.63% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?